Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Proteasome inhibition as a therapeutic strategy for hematologic malignancies.

Proteasome inhibition as a therapeutic strategy for hematologic malignancies. Expert Rev Anticancer Ther. 2005 Jun; 5(3):465-76.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.